SCHEMBL230497

SCHEMBL230497

CC(C)OC(=O)C=CC#N

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 2/20 0.56
CA12 O43570 1/20 0.43
AKR1B10 O60218 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
AKR1B1 P15121 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
TSHR P16473 1/20 0.39
KDM4E B2RXH2 1/20 0.35
GLA P06280 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
RECQL P46063 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
XPO1 O14980 1/20 0.32
ALDH1A1 P00352 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16048992 0.81 HCAR2 (0.36) HCAR2
SCHEMBL178194 0.80 HCAR2 (0.80) HCAR2CA12AKR1B10CA1CA2
SCHEMBL177748 0.80 HCAR2 (0.80) HCAR2CA12AKR1B10CA1CA2
SCHEMBL177747 0.80 HCAR2 (0.80) HCAR2CA12AKR1B10CA1CA2
SCHEMBL1333356 0.79 HCAR2 (0.35) HCAR2MAPT
SCHEMBL11813430 0.78 HCAR2 (0.38) HCAR2CA12AKR1B10CA1CA2
SCHEMBL27659116 0.78 HCAR2 (0.76) HCAR2CA12AKR1B10CA1CA2
SCHEMBL5889387 0.77 CTSK (0.33) HCAR2
SCHEMBL18420319 0.77 HCAR2 (0.33) HCAR2TSHR
SCHEMBL35727 0.77 HCAR2 (0.33) HCAR2KDM4EMAPTHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 486 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260112694-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2026-04-23 US claimed
US-20260088310-A1 SHAPED BATTERY CELL AND METHOD OF MANUFACTURE Anthro Energy, Inc. (US) 2026-03-26 US claimed
EP-4127003-B1 HYBRID LIGHT-CURING COMPOSITION DYMAX CORP (US) 2025-11-12 EP claimed
US-20250149631-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2025-05-08 US claimed
WO-2025091014-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2025-05-01 WO claimed
CN-116209729-B Thickener for cyanoacrylate-based adhesives 旭化成株式会社 2025-04-08 CN claimed
CN-119233828-A Nano encapsulated pharmaceutical composition and use thereof 福君基因公司 2024-12-31 CN claimed
CN-119212725-A Polymer nano aggregate pharmaceutical composition and application thereof ANP科技公司 2024-12-27 CN claimed
CN-114621398-B Stretchable cyanoacrylate tissue adhesives and uses thereof 香港科技大学 2024-04-30 CN claimed
CN-117377706-A Two-part curable composition 博斯蒂克股份公司 2024-01-09 CN claimed
US-5383899-A Method of using a surface opening adhesive sealer HEMODYNAMICS, INC. 1995-01-24 US claimed
EP-0596745-A1 Fingernail adhesive THREE BOND OF AMERICA, INC. (US) 1994-05-11 EP claimed
EP-0155952-B1 CYANOACRYLATE FINGERPRINT DEVELOPMENT METHOD LOCTITE CORPORATION (US) 1990-04-11 EP claimed
US-4719119-A FROM THIN FILM EVAPORATION LOCTITE CORPORATION (US) 1988-01-12 US claimed
EP-0155952-A4 CYANOACRYLATE FINGERPRINT DEVELOPMENT METHOD. LOCTITE CORP (US) 1985-12-05 EP claimed
EP-0155952-A1 CYANOACRYLATE FINGERPRINT DEVELOPMENT METHOD. LOCTITE CORP (US) 1985-10-02 EP claimed
US-4526544-A Cyanoacrylate root canal sealer KAHN HENRY 1985-07-02 US claimed
WO-1985000963-A1 CYANOACRYLATE FINGERPRINT DEVELOPMENT METHOD LOCTITE CORPORATION (US) 1985-03-14 WO claimed
US-4425471-A HEAT AND WATER RESISTANT MINNESOTA MINING & MANUFACTURING COMPANY (US) 1984-01-10 US claimed
US-4032495-A WATER-REPELLENT AND OIL-REPELLENT COMPOSITIONS BASED ON FLUORINE COMPOUND PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1977-06-28 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260088310-A1 SHAPED BATTERY CELL AND METHOD OF MANUFACTURE FTO, DCX, TET1 HCAR2 3507/4885CA12 312/4885AKR1B10 2448/4885
US-20260112694-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES PARG, PUF60, PHOSPHO1 HCAR2 3113/4885CA12 764/4885AKR1B10 3334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.